China Innovation Investment Limited (1217) AI Stock Analysis

• Market Cap: HK$204.83M
• Dividend Yield: N/A
• Average Volume (3M): 30.74M
• Price to Earnings (P/E): 10.0
• Beta (1Y): 0.98
• Revenue Growth: 38.96%
• EPS Growth: 700.00%
• Country: HK
• Employees: 16
• Sector: Financial
• Sector Strength: 70
• Industry: Asset Management
• EPS (TTM): <0.01
• Shares Outstanding: 12,801,579,000
• 10 Day Avg. Volume: 35,769,200
• 30 Day Avg. Volume: 30,737,253
• PEG Ratio: 0.26
• Price to Book (P/B): 0.24
• Price to Sales (P/S): 6.33
• P/FCF Ratio: 0.72
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 50 Neutral
• Price Target: HK$0.00 ▼(-100.00% Downside)

The overall stock score reflects significant financial risks due to historical volatility and poor cash flow management, despite strong recent revenue growth and a solid balance sheet. Technical indicators suggest neutral momentum with potential for upward movement, while valuation appears fair. The absence of earnings call data and corporate events limits additional insights.

China Innovation Investment Limited Business Overview & Revenue Model

Company Description

China Innovation Investment Limited (1217) is an investment holding company based in Hong Kong, primarily focused on identifying and investing in innovative sectors within the Greater China region. The company operates across various industries, including technology, healthcare, and consumer products, aiming to capitalize on emerging market trends and growth opportunities. Its core services involve venture capital investments, equity investments, and strategic partnerships to support the growth of its portfolio companies.

How the Company Makes Money

China Innovation Investment Limited generates revenue through a diversified investment portfolio, focusing on equity stakes in high-potential companies within innovative sectors. Its revenue model primarily includes capital appreciation from its investments, as well as potential dividends received from portfolio companies. The company may also earn management fees from funds it manages and performance fees based on the returns generated for its investors. Significant partnerships with other investment firms and strategic alliances in targeted industries contribute to its earnings by providing access to additional resources and opportunities for collaboration.

China Innovation Investment Limited Financial Statement Overview

Summary

The company has shown strong revenue growth and profit margins in 2024, but historical volatility and poor cash flow management raise concerns about sustainability. The balance sheet is robust with low leverage, but the lack of cash flow stability is a significant risk.

Income Statement

The company has shown significant revenue growth from 2023 to 2024, with a 549.5% increase. Gross profit margin is strong at 100%, indicating all revenue is contributing to profit. However, the historical volatility in revenue and net income, especially losses in 2021, raises concerns about stability. The net profit margin of 24.7% in 2024 is positive, but past inconsistencies impact the score.

Balance Sheet

The balance sheet is strong with a high equity ratio of 98.9% in 2024, indicating low financial leverage and a solid financial structure. The debt-to-equity ratio is minimal at 0.3%, reflecting low risk from debt obligations. The return on equity for 2024 is 0.9%, suggesting moderate efficiency in utilizing shareholder equity to generate profits.

Cash Flow

The cash flow statement shows a concerning lack of operating, investing, and financing cash flows in 2024, indicating potential issues with cash management or reporting. The absence of free cash flow growth and a historical pattern of negative cash flows highlight risks in liquidity and operational efficiency.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	39.24M	20.26M	3.12M	34.38M	-26.73M	-3.64M
Gross Profit	39.24M	20.26M	9.53M	12.16M	-27.62M	-4.55M
EBITDA	19.70M	5.91M	3.24M	6.64M	-32.94M	-9.03M
Net Income	19.97M	5.00M	2.19M	5.76M	-34.01M	-9.81M
Balance Sheet
Total Assets	616.73M	548.58M	550.22M	564.03M	612.68M	656.35M
Cash, Cash Equivalents and Short-Term Investments	323.35M	299.84M	177.96M	137.63M	156.54M	225.14M
Total Debt	934.00K	1.38M	2.23M	475.00K	1.39M	2.26M
Total Liabilities	50.95M	5.87M	2.55M	770.00K	1.68M	2.60M
Stockholders Equity	565.78M	542.71M	547.67M	563.26M	611.00M	653.75M
Cash Flow
Free Cash Flow	9.13M	178.84M	28.56M	-15.37M	-19.35M	-1.77M
Operating Cash Flow	9.13M	178.84M	28.62M	-14.95M	-19.35M	-1.77M
Investing Cash Flow	-8.56M	-4.97M	6.18M	9.14M	16.79M	6.78M
Financing Cash Flow	-880.00K	-854.00K	-883.00K	-915.00K	-871.00K	-894.00K

China Innovation Investment Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.02
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1217, the sentiment is Positive. The current price of 0.02 is above the 20-day moving average (MA) of 0.01, above the 50-day MA of 0.02, and above the 200-day MA of 0.01, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 65.56 is Neutral, neither overbought nor oversold. The STOCH value of 73.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1217.

China Innovation Investment Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
0768	65 Neutral	HK$50.87M	4.94	11.69%	―	50.11%	―
1217	50 Neutral	HK$204.83M	10.00	3.56%	―	38.96%	700.00%
2312	50 Neutral	HK$553.65M	54.51	11.27%	―	99.09%	―
0033	41 Neutral	HK$223.30M	-14.13	―	―	9.10%	66.31%

China Innovation Investment Limited Corporate Events

China Innovation Partners with Jiangsu Lizhuo for AI in Agriculture

China Innovation Investment Limited has entered into a strategic investment framework agreement with Jiangsu Lizhuo Information Technology Co., Ltd. to promote the application of artificial intelligence in agriculture. This collaboration aims to leverage Jiangsu Lizhuo’s technological strengths to expand its market presence and develop integrated AI solutions for agriculture, with plans for nationwide and overseas expansion, particularly in Southeast Asia and the Belt and Road regions.

China Innovation Investment Limited Announces Partial Offer for Elife Holdings Shares

China Innovation Investment Limited has announced the despatch of an offer document related to a voluntary conditional cash partial offer by Mango Financial Limited to acquire 180,000,000 shares in Elife Holdings Limited. This move is part of a series of announcements made by the company throughout 2025. The offer document, which includes terms and conditions of the partial offer, has been sent to shareholders and is available on the Stock Exchange’s website. The timetable for the offer is outlined, with key dates for acceptance and announcement of results specified, indicating a strategic move to potentially increase its stake in Elife Holdings Limited.

China Innovation Investment Limited Reports Net Asset Value Update

China Innovation Investment Limited announced that its unaudited net asset value per share as of September 30, 2025, was approximately HK$0.047. This financial update provides stakeholders with insight into the company’s current financial standing, which may influence investor confidence and market perception.

China Innovation Investment Limited Announces EGM for Strategic Acquisition

China Innovation Investment Limited has announced an extraordinary general meeting (EGM) to be held on October 28, 2025, in Hong Kong. The meeting will consider a resolution regarding a conditional voluntary partial cash offer by Mango Financial Limited, on behalf of China Innovation Investment Limited, to acquire a significant portion of shares in Elife Holdings Limited. This strategic move aims to strengthen the company’s market position and influence within the industry.

China Innovation Investment Limited Reports Net Asset Value Update

China Innovation Investment Limited announced that its unaudited net asset value per share was approximately HK$ 0.045 as of 31 August 2025. This financial update provides stakeholders with insights into the company’s current valuation, potentially impacting investor perceptions and market positioning.

China Innovation Investment Limited Announces Change in Company Secretary

China Innovation Investment Limited has announced a change in its company secretary and authorized representative. Ms. Choi Yan Ting has resigned to focus on personal commitments, and Mr. Wong Kwok Chung, with extensive experience in auditing, finance, and company secretarial roles, has been appointed as her successor. This transition is expected to maintain the company’s operational stability and compliance with listing regulations.

China Innovation Investment Limited Reports Strong Interim Results for 2025

China Innovation Investment Limited reported a significant increase in turnover for the first half of 2025, reaching approximately HK$683.3 million compared to HK$269.7 million in the same period of 2024. The company’s revenue also saw a rise, driven by gains from the disposal of investments, despite facing unrealized holding losses. The profit for the period attributable to owners was HK$23.1 million, indicating a strong financial performance and potential positive implications for stakeholders.